These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6268349)
21. [Effect of a water-soluble derivative of silymarin on morphological and functional alterations of mouse hepatocytes induced by Frog Virus 3 (author's transl)]. Gendrault JL; Steffan AM; Elharrar M; Kirn A Arzneimittelforschung; 1979; 29(5):786-91. PubMed ID: 582977 [TBL] [Abstract][Full Text] [Related]
25. [Therapy of hepatoses. Therapeutic use of Silymarin]. Schopen RD; Lange OK Med Welt; 1970 Apr; 15():691-8. PubMed ID: 5523243 [No Abstract] [Full Text] [Related]
26. [Silymarin and various problems of current therapy of chronic liver diseases]. Fassati P; Fassati M Cas Lek Cesk; 1973; 112(28):865-9. PubMed ID: 4720441 [No Abstract] [Full Text] [Related]
27. [[The Pathogenetic Approaches to the Chronic Liver Diseases Treatment].]. Golovanova EV Eksp Klin Gastroenterol; 2016; (5):65-73. PubMed ID: 28614647 [TBL] [Abstract][Full Text] [Related]
28. [Therapy of liver diseases using Silymarin (Legalon)]. Milosavljevic Z Ther Ggw; 1973 Jun; 112(6):968 passim. PubMed ID: 4200154 [No Abstract] [Full Text] [Related]
30. [Detoxic, protein-synthesizing function and resistance of hepatocytes in patients with chronic diffuse liver diseases during the treatment with legalon]. Dehtiar'ova II; Skrypnyk IM; Kozachok MM; Kuts TV Lik Sprava; 2004 Dec; (8):70-6. PubMed ID: 15771078 [TBL] [Abstract][Full Text] [Related]
31. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases]. Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425 [TBL] [Abstract][Full Text] [Related]
32. [Effect of promazine on the activity of some liver and blood enzymes in carbon tetrachloride poisoning]. Pokrovskiĭ AA; Archakov AI; Devichenskiĭ VM Vopr Med Khim; 1965; 11(3):64-7. PubMed ID: 4287794 [No Abstract] [Full Text] [Related]
33. [Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats]. Siegers CP Z Gastroenterol; 1982 Dec; 20(12):757-8. PubMed ID: 7164529 [No Abstract] [Full Text] [Related]
34. [Use of silymarin in the treatment of alcoholic hepatic steatosis]. Canini F; Bartolucci L; Cristallini E; Gradoli C; Rossi A; Ribacchi R; Valori C Clin Ter; 1985 Aug; 114(4):307-14. PubMed ID: 4053546 [No Abstract] [Full Text] [Related]
36. [Effect of carsil and legalon in treating chronic liver diseases]. Brailski Kh; Chernev K; Etŭrska M; Donov M; Velev G Vutr Boles; 1986; 25(3):43-9. PubMed ID: 3765578 [TBL] [Abstract][Full Text] [Related]
37. The effects of silymarin on experimental phalloidine poisoning. Desplaces A; Choppin J; Vogel G; Trost W Arzneimittelforschung; 1975 Jan; 25(1):89-96. PubMed ID: 125090 [TBL] [Abstract][Full Text] [Related]
38. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Pradhan SC; Girish C Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517 [TBL] [Abstract][Full Text] [Related]
39. [Alcoholic hepatopathy. Aspects of drug therapy]. Del Dotto M; Neri D G Clin Med; 1982 Apr; 63(4):228-36. PubMed ID: 7128979 [No Abstract] [Full Text] [Related]
40. Re: Flora et al. Silymarin for the therapy of liver disease. Bode JC Am J Gastroenterol; 1999 Feb; 94(2):545-6. PubMed ID: 10022676 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]